Study to Assess the Effect of a CYP3A Weak Inducer Rufinamide on Quizartinib Pharmacokinetics in Healthy Subjects
Clinical trial NCT06740825 · COMPLETED
Trial details
- NCT number
- NCT06740825
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-29
- Primary completion
- 2024-12-09
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.